The symptoms from gastrointestinal motility disorders are common and can range from slight discomfort and inconvenience to outcomes with serious medical consequences.
GI Therapies is focussing on those disorders that give rise to chronic constipation that are primarily a result of poor motility in the lower bowel.
Constipation is a common symptom in children and adults, males and females and across most ethnic groups1. In many cases, the problem is transient and well managed with laxatives, osmotic agents, bulking agents, behavioural therapy and other related first line therapies. Nevertheless, in some patients these agents and approaches are not sufficient and the condition remains chronic and unresolved, often for many years. For these patients, there is a significant impact on their quality of life and economic burden2,3. In some cases, surgery and other more invasive interventional procedures are required.
In addition to causes that are unknown, constipation is also associated with the use of medications such as analgesics, antihypertensive and antiparkinsonian drugs, medical conditions such as various metabolic diseases and mechanical obstruction. The American Gastroenterological Association Technical Review on Constipation4 summarises current thinking around the diagnosis and treatment of this pervasive condition.